Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Supreme Court Of India
2002 Gujarat Riots
Enforcement Directorate (ED)
Maharashtra Government
University Grants Commission
Alt News
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / India to have 8 vaccines by year-end. Which are they?
India

India to have 8 vaccines by year-end. Which are they?

India to have 8 vaccines by year-end. Which are they?
Written by Sagar
May 14, 2021, 11:21 am 3 min read
India to have 8 vaccines by year-end. Which are they?
India will have 216 crore vaccine doses by December

India plans to inoculate all its citizens against the coronavirus by the end of this year - a significant development for a nation that has been ravaged by a brutal second wave of the pandemic. A whopping 216 crore doses will be made available and eight different vaccines will be used for the massive drive, a top government official said. Here's more about them.

Quote
'Vaccines will be available for all'

"Overall, 216 crore doses of vaccines will be manufactured in India between August and December, for India and for Indians. There should be no doubt that vaccines will be available for all as we move forward," said Dr. VK Paul, NITI Aayog member (Health).

Vaccine 1
COVAXIN

COVAXIN is India's first approved indigenous coronavirus vaccine. It has been developed by the Hyderabad-based firm Bharat Biotech in collaboration with the National Institute of Virology (NIV) and the Indian Council of Medical Research (ICMR). Trial results showed the vaccine has an efficacy of 78 percent. At least 55 crore doses of COVAXIN would be available by December, the government has said.

Vaccine 2
Covishield

Covishield is the Indian brand name of the anti-coronavirus vaccine developed by the University of Oxford in partnership with the British-Swedish company AstraZeneca. It is being locally produced by the Pune-based Serum Institute of India. The vaccine has shown to be 63 percent effective in clinical trials. At least 75 crore doses of Covishield will be made available by the end of the year.

Vaccine 3
Sputnik V

It is the latest anti-COVID-19 vaccine to be approved by the top Indian drug regulator. The vaccine has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Ministry of Health. It is said to be as much as 91.6 percent effective. The government plans to roll out 15.6 crore doses of the vaccine by December.

Vaccine 4
Biological E vaccine

Hyderabad-based pharmaceutical firm Biological E Limited (BE) has developed the BECOV2A vaccine. Rather than injecting a whole pathogen, this vaccine contains purified pieces selected for their ability to stimulate a strong immune response. Vaccines of such nature are believed to be safer and relatively affordable. The company has been tasked to produce at least 30 crore doses of the vaccine this year.

Vaccine 5
Zydus Cadila vaccine

Zydus Cadila, the Ahmedabad-based pharmaceutical company, has developed its plasmid DNA vaccine called ZyCoV-D. Vaccines of this type use genetic material from a disease-causing virus or bacteria in order to trigger an immune response against it. ZyCoV-D is reportedly a three-dose vaccine. Five crore doses of the vaccine are expected to be available by this December.

Vaccine 6
Novavax vaccine

NVX-CoV2373, branded Covovax, has been developed by the United States-based vaccine maker Novavax and will be made available in India in partnership with the Serum Institute of India. The protein-based anti-coronavirus vaccine has shown an efficacy of 89.3 percent in its Phase three clinical trials conducted in the United Kingdom, the company said. Serum Institute will supply 20 crore doses of Covovax by December.

Other vaccines
Gennova vaccine and Intranasal

Gennova: It has been developed by the Pune-based Gennova Biopharmaceuticals Limited. The government said six crore doses of this vaccine will be available by December. Intranasal: It has been prepared by COVAXIN producer Bharat Biotech. It is a nasal vaccine, implying it can be administered through the nose and does not require a needle. 10 crore doses of the vaccine will be rolled out.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
India
Vaccine
Coronavirus
Related
Latest
India beat Ireland in 2nd T20I, seal two-match series 2-0
India beat Ireland in 2nd T20I, seal two-match series 2-0 Sports
Moto G42's India launch on July 4: Check expected price
Moto G42's India launch on July 4: Check expected price Technology
2022 Wimbledon: Rafael Nadal claims first-round win over Francisco Cerundolo
2022 Wimbledon: Rafael Nadal claims first-round win over Francisco Cerundolo Sports
Who is Mohammed Zubair, journalist arrested for hurting religious sentiments?
Who is Mohammed Zubair, journalist arrested for hurting religious sentiments? India
Arrested Punjab IAS officer Sanjay Popli attends son's funeral
Arrested Punjab IAS officer Sanjay Popli attends son's funeral India
India
Sri Lanka under virtual lockdown over fuel scarcity amid crisis
Sri Lanka under virtual lockdown over fuel scarcity amid crisis World
Man left behind by 'baraat' sues groom for Rs. 50L
Man left behind by 'baraat' sues groom for Rs. 50L Lifestyle
Pallonji Mistry, chairman of Shapoorji Pallonji Group, dies at 93
Pallonji Mistry, chairman of Shapoorji Pallonji Group, dies at 93 Business
Congress reaches out to like-minded parties for 'Bharat Jodo Yatra'
Congress reaches out to like-minded parties for 'Bharat Jodo Yatra' Politics
5 Western dance styles for those who love dancing
5 Western dance styles for those who love dancing Lifestyle
More News
Vaccine
COVID-19: India logs 11,793 new cases, 27 more deaths
COVID-19: India logs 11,793 new cases, 27 more deaths India
COVID-19: India reports 17,073 new cases; 21 more deaths
COVID-19: India reports 17,073 new cases; 21 more deaths India
COVID-19: India logs 12,249 fresh cases, 13 more fatalities
COVID-19: India logs 12,249 fresh cases, 13 more fatalities India
COVID-19: India logs 9,923 fresh cases, 17 more fatalities
COVID-19: India logs 9,923 fresh cases, 17 more fatalities India
COVID-19: India logs 12,899 fresh cases, 15 more deaths
COVID-19: India logs 12,899 fresh cases, 15 more deaths India
More News
Coronavirus
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
COVID-19: India logs 7,584 fresh cases, 24 more fatalities
COVID-19: India logs 7,584 fresh cases, 24 more fatalities India
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
More News
Related
COVID-19 vaccines prevented 42L deaths in India in 2021: Report
COVID-19 vaccines prevented 42L deaths in India in 2021: Report India
High vaccination coverage helped India defeat COVID-19 third wave: Report
High vaccination coverage helped India defeat COVID-19 third wave: Report India
COVID-19 vaccination for 12-14-year-olds to start from Wednesday: Details here
COVID-19 vaccination for 12-14-year-olds to start from Wednesday: Details here India
COVID-19 oral vaccine's clinical trial to begin in India soon
COVID-19 oral vaccine's clinical trial to begin in India soon India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022